The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions
Abstract
Cost‐effectiveness acceptability curves (CEACs) have been widely adopted as a method to quantify and graphically represent uncertainty in economic evaluation studies of health‐care technologies. However, there remain some common fallacies regarding the nature and shape of CEACs that largely result from the ‘textbook’ illustration of the CEAC. This ‘textbook’ CEAC shows a smooth curve starting at probability 0, with an asymptote to 1 for higher money values of the health outcome (λ). But this familiar ‘ogive’ shape which makes the ‘textbook’ CEAC look like a cumulative distribution function is just one special case of the CEAC. The reality is that the CEAC can take many shapes and turns because it is a graphic transformation from the cost‐effectiveness plane, where the joint density of incremental costs and effects may ‘straddle’ quadrants with attendant discontinuities and asymptotes. In fact CEACs: (i) do not have to cut the y‐axis at 0; (ii) do not have to asymptote to 1; (iii) are not always monotonically increasing in λ; and (iv) do not represent cumulative distribution functions (cdfs). Within this paper we present a ‘gallery’ of CEACs in order to identify the fallacies and illustrate the facts surrounding the CEAC. The aim of the paper is to serve as a reference tool to accompany the increased use of CEACs within major medical journals. Copyright © 2004 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Representing uncertainty: the role of cost‐effectiveness acceptability curves
Fenwick, E., Claxton, K., & Sculpher, M. (2001) · Health Economics · doi:10.1002/hec.635 · Cited by 1,110
Self-citationCosts, effects and C/E‐ratios alongside a clinical trial
Van Hout, B. A., Al, M. J., Gordon, G. S., & Rutten, F. F. H. (1994) · Health Economics · doi:10.1002/hec.4730030505 · Cited by 964
Claxton, K. (1999) · Journal of Health Economics · doi:10.1016/s0167-6296(98)00039-3 · Cited by 889
The CE Plane: A Graphic Representation of Cost-Effectiveness
Black, W. C. (1990) · Medical Decision Making · doi:10.1177/0272989x9001000308 · Cited by 581
A rational framework for decision making by the National Institute for Clinical Excellence (NICE)
Claxton, K., Sculpher, M., & Drummond, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09832-x · Cited by 456
Handling uncertainty when performing economic evaluation of healthcare interventions.
Briggs, & Gray (1999) · Health Technology Assessment · doi:10.3310/hta3020 · Cited by 387
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · Cited by 302
Definition, interpretation and calculation of cost-effectiveness acceptability curves
L�thgren, M., & Zethraeus, N. (2000) · Health Economics · doi:10.1002/1099-1050(200010)9:7<623::aid-hec539>3.0.co;2-v · Cited by 292
Cited by
UK BEAM Trial Team (2004) · BMJ · doi:10.1136/bmj.38282.669225.ae · Cited by 518
Coates, L. C., Moverley, A. R., McParland, L., Brown, S., Navarro-Coy, N., O'Dwyer, J. L., Meads, D. M., Emery, P., Conaghan, P. G., & Helliwell, P. S. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00347-5 · Cited by 476
A guide to cost-effectiveness acceptability curves
Fenwick, E., & Byford, S. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.187.2.106 · Cited by 420
Self-citationCucchetti, A., Piscaglia, F., Cescon, M., Colecchia, A., Ercolani, G., Bolondi, L., & Pinna, A. D. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.009 · Cited by 407
Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting
Petrou, S., & Gray, A. (2011) · BMJ · doi:10.1136/bmj.d1548 · Cited by 318
Propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias
López Bastida, J., Oliva, J., Antoñanzas, F., García-Altés, A., Gisbert, R., Mar, J., & Puig-Junoy, J. (2010) · Gaceta Sanitaria · doi:10.1016/j.gaceta.2009.07.011 · Cited by 311
Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting
Petrou, S., & Gray, A. (2011) · BMJ · doi:10.1136/bmj.d1766 · Cited by 292
Barton, G. R., Briggs, A. H., & Fenwick, E. A. L. (2008) · Value in Health · doi:10.1111/j.1524-4733.2008.00358.x · Cited by 290
Self-citationTruby, H., Baic, S., deLooy, A., Fox, K. R., Livingstone, M. B. E., Logan, C. M., Macdonald, I. A., Morgan, L. M., Taylor, M. A., & Millward, D. J. (2006) · BMJ · doi:10.1136/bmj.38833.411204.80 · Cited by 284
Fenwick, E., Marshall, D. A., Levy, A. R., & Nichol, G. (2006) · BMC Health Services Research · doi:10.1186/1472-6963-6-52 · Cited by 279
Self-citationTitov, N., Dear, B. F., Ali, S., Zou, J. B., Lorian, C. N., Johnston, L., Terides, M. D., Kayrouz, R., Klein, B., Gandy, M., et al. (2015) · Behavior Therapy · doi:10.1016/j.beth.2014.09.008 · Cited by 210
Statistical Analysis of Cost‐effectiveness Data
Willan, A. R., & Briggs, A. H. (2006) · doi:10.1002/0470856289 · Cited by 155
Self-citationKleiboer, A., Smit, J., Bosmans, J., Ruwaard, J., Andersson, G., Topooco, N., Berger, T., Krieger, T., Botella, C., Baños, R., et al. (2016) · Trials · doi:10.1186/s13063-016-1511-1 · Cited by 133
Gerhards, S. A. H., de Graaf, L. E., Jacobs, L. E., Severens, J. L., Huibers, M. J. H., Arntz, A., Riper, H., Widdershoven, G., Metsemakers, J. F. M., & Evers, S. M. A. A. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.065748 · Cited by 135
Rudmik, L., Soler, Z. M., Mace, J. C., Schlosser, R. J., & Smith, T. L. (2015) · The Laryngoscope · doi:10.1002/lary.24916 · Cited by 130
Dear, B. F., Zou, J. B., Ali, S., Lorian, C. N., Johnston, L., Sheehan, J., Staples, L. G., Gandy, M., Fogliati, V. J., Klein, B., et al. (2015) · Behavior Therapy · doi:10.1016/j.beth.2014.09.007 · Cited by 108
Uncertainty and patient heterogeneity in medical decision models
Groot Koerkamp, B., Weinstein, M. C., Stijnen, T., Heijenbrok-Kal, M. H., & Hunink, M. G. M. (2010) · Medical Decision Making · doi:10.1177/0272989x09342277 · Cited by 105
Hendriks, J., Tomini, F., van Asselt, T., Crijns, H., & Vrijhoef, H. (2013) · Europace · doi:10.1093/europace/eut055 · Cited by 100
Kooistra, L. C., Wiersma, J. E., Ruwaard, J., Neijenhuijs, K., Lokkerbol, J., van Oppen, P., Smit, F., & Riper, H. (2019) · Journal of Medical Internet Research · doi:10.2196/14261 · Cited by 84
Cost-Effectiveness of Treatments for Adolescent Depression: Results From TADS
Domino, M. E., Burns, B. J., Silva, S. G., Kratochvil, C. J., Vitiello, B., Reinecke, M. A., Mario, J., & March, J. S. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07101610 · Cited by 92
Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature
Ghatnekar, O., Andersson, R., Svensson, M., Persson, U., Ringdahl, U., Zeilon, P., & Borrebaeck, C. A. K. (2013) · International Journal of Cancer · doi:10.1002/ijc.28256 · Cited by 85
Neelemaat, F., Bosmans, J. E., Thijs, A., Seidell, J. C., & van Bokhorst-de van der Schueren, M. A. E. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2011.10.009 · Cited by 84
Kolovos, S., van Dongen, J. M., Riper, H., Buntrock, C., Cuijpers, P., Ebert, D. D., Geraedts, A. S., Kenter, R. M., Nobis, S., Smith, A., et al. (2018) · Depression and Anxiety · doi:10.1002/da.22714 · Cited by 63
Kimman, M. L., Dirksen, C. D., Voogd, A. C., Falger, P., Gijsen, B. C. M., Thuring, M., Lenssen, A., van der Ent, F., Verkeyn, J., Haekens, C., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.12.017 · Cited by 66
Kampshoff, C. S., van Dongen, J. M., van Mechelen, W., Schep, G., Vreugdenhil, A., Twisk, J. W. R., Bosmans, J. E., Brug, J., Chinapaw, M. J. M., & Buffart, L. M. (2018) · Journal of Cancer Survivorship · doi:10.1007/s11764-018-0681-0 · Cited by 62
Cost–utility and cost-effectiveness of physical exercise during adjuvant chemotherapy
van Waart, H., van Dongen, J. M., van Harten, W. H., Stuiver, M. M., Huijsmans, R., Hellendoorn-van Vreeswijk, J. A. J. H., Sonke, G. S., & Aaronson, N. K. (2018) · The European Journal of Health Economics · doi:10.1007/s10198-017-0936-0 · Cited by 56
Gates, S., Lall, R., Quinn, T., Deakin, C. D., Cooke, M. W., Horton, J., Lamb, S. E., Slowther, A.-M., Woollard, M., Carson, A., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21110 · Cited by 62
Rolving, N., Sogaard, R., Nielsen, C. V., Christensen, F. B., Bünger, C., & Oestergaard, L. G. (2016) · SPINE · doi:10.1097/brs.0000000000001254 · Cited by 59
Yang, C.-Y., Chen, Y.-R., Ou, H.-T., & Kuo, S. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01211-4 · Cited by 51
MacNeil Vroomen, J., Bosmans, J. E., Eekhout, I., Joling, K. J., van Mierlo, L. D., Meiland, F. J. M., van Hout, H. P. J., & de Rooij, S. E. (2016) · PLOS ONE · doi:10.1371/journal.pone.0160908 · Cited by 48
Cost-effectiveness of a classification-based system for sub-acute and chronic low back pain
Apeldoorn, A. T., Bosmans, J. E., Ostelo, R. W., de Vet, H. C. W., & van Tulder, M. W. (2012) · European Spine Journal · doi:10.1007/s00586-011-2144-4 · Cited by 35
van Dongen, J. M., van Berkel, J., Boot, C. R. L., Bosmans, J. E., Proper, K. I., Bongers, P. M., van der Beek, A. J., van Tulder, M. W., & van Wier, M. F. (2016) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0000000000000736 · Cited by 36
Bolinski, F., Kleiboer, A., Karyotaki, E., Bosmans, J. E., Zarski, A.-C., Weisel, K. K., Ebert, D. D., Jacobi, C., Cuijpers, P., & Riper, H. (2018) · Trials · doi:10.1186/s13063-018-2477-y · Cited by 31
Is exposure in vivo cost-effective for chronic low back pain? A trial-based economic evaluation
Goossens, M. E. J. B., de Kinderen, R. J. A., Leeuw, M., de Jong, J. R., Ruijgrok, J., Evers, S. M. A. A., & Vlaeyen, J. W. S. (2015) · BMC Health Services Research · doi:10.1186/s12913-015-1212-6 · Cited by 29
Schröder, A., Ørnbøl, E., Jensen, J. S., Sharpe, M., & Fink, P. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.01.005 · Cited by 25
Lemmers, M., Verschoor, M. A. C., Bossuyt, P. M., Huirne, J. A. F., Spinder, T., Nieboer, T. E., Bongers, M. Y., Janssen, I. A. H., Van Hooff, M. H. A., Mol, B. W. J., et al. (2018) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.13283 · Cited by 23
Cox, H., Tilbrook, H., Aplin, J., Chuang, L.-H., Hewitt, C., Jayakody, S., Semlyen, A., Soares, M. O., Torgerson, D., Trewhela, A., et al. (2010) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2009.09.010 · Cited by 21
“This uncertainty will be interpreted through both bootstrap and graphical methods.(22,23) For such, cost-effectiveness planes and cost-effectiveness acceptability curves (CEAC) will be plotted.”
Saha, S., Jarl, J., Gerdtham, U.-G., Sundquist, K., & Sundquist, J. (2020) · The British Journal of Psychiatry · doi:10.1192/bjp.2018.247 · Cited by 20
Finnes, A., Hoch, J. S., Enebrink, P., Dahl, J., Ghaderi, A., Nager, A., & Feldman, I. (2022) · Scandinavian Journal of Work, Environment & Health · doi:10.5271/sjweh.4012 · Cited by 17
“The likelihood of each intervention being more favorable compared to TAU was presented using cost‐effectiveness acceptability curves (CEAC) across a range of WTP thresholds (24).”
Kuo, S., Ye, W., Wang, D., McEwen, L. N., Villatoro Santos, C., & Herman, W. H. (2025) · Diabetes Care · doi:10.2337/dc24-1110 · Cited by 19
Cost‐effectiveness of CBT, SSRI, and CBT+SSRI in the treatment for panic disorder
van Apeldoorn, F. J., Stant, A. D., van Hout, W. J. P. J., Mersch, P. P. A., & den Boer, J. A. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12169 · Cited by 19
Lee, T., Kuo, S., Yang, C., & Ou, H. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14188 · Cited by 18
Vollbehr, N. K., Hoenders, H. J. R., Bartels‐Velthuis, A. A., Nauta, M. H., Castelein, S., Schroevers, M. J., Stant, A. D., de Jong, P. J., & Ostafin, B. D. (2020) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1820 · Cited by 16
Bosmans, J. E., Schreuders, B., van Marwijk, H. W., Smit, J. H., van Oppen, P., & van Tulder, M. W. (2012) · BMC Family Practice · doi:10.1186/1471-2296-13-98 · Cited by 16
“The ceiling ratio is defined as the amount of money society is willing to pay to gain one unit of effect [35].”
BackgroundMoessner, M., Bauer, S., Özer, F., Wolf, M., Zimmer, B., & Kordy, H. (2014) · Psychotherapy Research · doi:10.1080/10503307.2013.845919 · Cited by 15
Moayeri, F., Dunt, D., Hsueh, Y.-S. (., & Doyle, C. (2019) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2019.1536550 · Cited by 15
Risør, B. W., Frydendal, D. H., Villemoes, M. K., Nielsen, C. P., Rask, C. U., & Frostholm, L. (2022) · PharmacoEconomics - Open · doi:10.1007/s41669-021-00319-x · Cited by 11
Kok, R. N., van Straten, A., Beekman, A., Bosmans, J., de Neef, M., & Cuijpers, P. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-131 · Cited by 12
Sun, Y., Wong, S. Y. S., Zhang, D., Chen, C. H. J., & Yip, B. H. K. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.10.006 · Cited by 11
Haji Ali Afzali, H., Gray, J., Beilby, J., Holton, C., & Karnon, J. (2013) · Applied Health Economics and Health Policy · doi:10.1007/s40258-013-0062-9 · Cited by 10
Terhorst, Y., Braun, L., Titzler, I., Buntrock, C., Freund, J., Thielecke, J., Ebert, D., & Baumeister, H. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034271 · Cited by 10
Daniëls, M., Van, H. L., van den Heuvel, B., Dekker, J. J. M., Peen, J., Bosmans, J., Arntz, A., & Huibers, M. J. H. (2023) · Trials · doi:10.1186/s13063-023-07136-z · Cited by 9
“Cost-effectiveness acceptability curves [36] will also be estimated.”
BackgroundSocial recovery therapy for young people with emerging severe mental illness: the Prodigy RCT
Fowler, D., Berry, C., Hodgekins, J., Banerjee, R., Barton, G., Byrne, R., Clarke, T., Fraser, R., Grant, K., Greenwood, K., et al. (2021) · Health Technology Assessment · doi:10.3310/hta25700 · Cited by 7
Wagner, A. P., Galante, J., Dufour, G., Barton, G., Stochl, J., Vainre, M., & Jones, P. B. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-071724 · Cited by 7
Metadata
- Authors
- Fenwick, E., O'Brien, B. J., & Briggs, A.
- Venue
- Health Economics
- Publisher
- Wiley
- Published
- 2004-04-29
- Volume
- 13
- Issue
- 5
- Pages
- 405-415
- ISSN
- 1057-9230 (ISSN-L)
- 1099-1050
- OpenAlex
- W2150106013
- Cited by
- 943
- References
- 31
- FWCI
- 67.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.